The California denial segment captures a specific configuration: the member holds a fully-insured plan issued in California, or a Knox-Keene licensee HMO/PPO plan (Health Net, Blue Shield of California, Aetna, Cigna, Kaiser Permanente CA products, Anthem Blue Cross), and has received an Adverse Benefit Determination on the EOB. The denial reason will track the carrier’s internal reason code (medical necessity, prior authorization, step therapy, formulary exclusion, out-of-network), but the appeal frameworks that attach are California-specific. The Department of Managed Health Care (DMHC) regulates Knox-Keene licensees under the Knox-Keene Health Care Service Plan Act of 1975 (Cal. Health & Safety Code § 1340 et seq.), and fully-insured PPO/EPO disputes fall under Cal. Ins. Code § 10169 — sections 10169 through 10169.15 spell out the carrier’s adverse-determination notice requirements, the internal-appeal window, and the Independent Medical Review (IMR) channel through the DMHC.
Knox-Keene Act licensees — the enrollee-facing HMOs and most PPOs operating in California — are subject to the DMHC’s Health & Safety Code § 1368 framework, which layers on top of any federal regime: a 60-day internal-appeal window after the ABD, a 180-day Independent Medical Review (IMR) deadline from the final internal denial, and the DMHC Help Center’s intervention channel (1-888-466-2219, online complaint form at www.dmhc.ca.gov). The California Department of Insurance (CDI) handles fully-insured PPO/EPO plans through Cal. Ins. Code § 10169 (notice requirements) and § 10169.2 (Independent Medical Review). Both IMR pathways are binding on the carrier, and the 7-day expedited IMR under § 1370.4(a) for ongoing care is the parallel to the federal 72-hour urgent-claim framing.
Self-funded ERISA plans — typically larger employer group plans where the employer pays the claims rather than buying insurance from a carrier — fall outside Knox-Keene and outside CDI, and run through the federal ERISA § 503 claims-procedure rule at 29 C.F.R. § 2560.503-1. CA UR laws (Cal. Health & Safety Code § 1363.5; Cal. Code Regs. tit. 28 § 1300.70) still apply to procedural aspects the federal rule does not preempt — clinical-criteria disclosure, peer-reviewer escalation, language-access requirements — but the appeals timeline and the right-to-file-a-civil-action follow fully from 29 C.F.R. § 2560.503-1 and ERISA § 502(a). A well-built California appeal letter cites both: the controlling CA statute (DMHC for Knox-Keene licensee plans, CDI for fully-insured PPO/EPO disputes, or the federal preemption fallback for self-funded ERISA), and the right federal framework underneath.